MCDERMOTT, WILL & EMERY – Trademark Portfolio
Entity Type: 02
MCDERMOTT, WILL & EMERY holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MWE and MCDERMOTT WILL & EMERY. The owner is based in Chicago, IL.
227 West Monroe Street
Chicago, IL 606065096
Showing of trademarks Trademarks
Trademark Classifications
MCDERMOTT, WILL & EMERY's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does MCDERMOTT, WILL & EMERY have?
MCDERMOTT, WILL & EMERY has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 2 cancelled.
What trademark classes does MCDERMOTT, WILL & EMERY file in?
MCDERMOTT, WILL & EMERY files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are MCDERMOTT, WILL & EMERY's most well-known trademarks?
MCDERMOTT, WILL & EMERY's registered trademark portfolio includes well-known marks such as MWE and MCDERMOTT WILL & EMERY. These are among 2 currently registered trademarks in the portfolio.
What is MCDERMOTT, WILL & EMERY's trademark registration success rate?
MCDERMOTT, WILL & EMERY has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.